Marshall Richard Peter

Marshall Richard Peter, Director, has filed 3 SEC reports (2025–2026), all concentrated in Serina Therapeutics, Inc. (SER), totaling $89.4K in disclosed volume. Weighing $20.1K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $20.1K in Serina Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.